Skip to main content
Equibles

GEODE CAPITAL MANAGEMENT, LLC

Position in MLTX — MoonLake Immunotherapeutics

CIK 1214717 BOSTON, MA
Back to MLTX Full portfolio

Position in MLTX

as of Jun 30, 2026 · filed Aug 12, 2026
Position Value
$1,455,577
+$108,483 QoQ
Shares Held
74,760
+3.4% QoQ
Ownership
0.088%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#76
of 172 holders
Holding Since
Dec 2022
15 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in MLTX Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

GEODE CAPITAL MANAGEMENT, LLC holds $22,039,427,018 across 520 Biotechnology names. MLTX ranks #300 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 VRTX
Vertex Pharmaceuticals Inc / Ma
 6,017,848 $2,989,245,636
2 REGN
Regeneron Pharmaceuticals, Inc.
 2,625,810 $1,637,297,566
3 ALNY
Alnylam Pharmaceuticals, Inc.
 2,635,840 $793,466,914
4 RVMD
Revolution Medicines, Inc.
 3,942,676 $738,384,360
5 MRNA
Moderna, Inc.
 9,710,335 $680,014,759
6 INCY
Incyte Corp
 4,750,735 $538,543,319
7 RPRX
Royalty Pharma plc
 8,058,048 $451,814,751
8 INSM
INSMED Inc
 4,220,155 $449,952,925

All Filings in MLTX

Export CSV
15 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $1,455,577 74,760
2026-03-31 $1,347,094 72,269
2025-12-31 $956,947 72,606
2025-09-30 $447,300 62,385
2025-06-30 $2,810,901 59,553
2025-03-31 $2,304,895 58,994
2024-12-31 $3,192,142 58,950
2024-09-30 $2,945,032 58,410
2024-06-30 $2,572,245 58,500
2024-03-31 $2,713,725 54,026
2023-12-31 $2,945,461 48,774
2023-09-30 $2,497,056 43,808
2023-06-30 $1,630,368 31,968
2023-03-31 $365,961 17,109
2022-12-31 $120,235 11,451